罗莫苏祖马布在纠正性脊柱融合手术中对近端结节的作用
Yuta Sawada1, Shinji Takahashi1, Hiroyuki Yasuda2
1Department of Orthopedics, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.
The spine journal : official journal of the North American Spine Society
|December 20, 2024
概括
在脊髓融合手术前服用罗莫苏祖马布显著降低了近端结节 (PJK) 和相关骨折 (PJK-Fx). 这种治疗改善了骨密度和减少并发症,提高了手术结果.
科学领域:
- 整形外科手术 整形外科手术
- 药理学 药理学是指药理学的学科.
- 骨的新陈代谢 骨的新陈代谢
背景情况:
- 靠近结节 (PJK) 和与PJK相关的骨折 (PJK-Fx) 是纠正脊柱融合手术后的重大并发症.
- 骨形成剂罗莫苏祖马布对手术患者这些并发症的影响在很大程度上仍未得到研究.
研究的目的:
- 评估romosozumab在缓解PJK,特别是PJK-Fx发病率的有效性,在接受脊柱正融合的患者中.
- 评估罗莫苏祖马布对骨矿物质密度和其他外科手术结果的影响.
主要方法:
- 一项回顾性队列研究,涉及111名50岁以上的患者,他们接受了纠正性脊髓融合.
- 患者被分为罗莫苏祖马布 (n=32) 和非罗莫苏祖马布 (n=79) 组,罗莫苏祖马布通常在手术前两个月服用.
- 主要结局:PJK发生率. 二级结局:霍恩斯菲尔德单位 (HU) 值,手术并发症和临床分数 (JOA,VAS).
主要成果:
- 罗莫苏祖马布显著增加了顶部仪器脊椎的骨密度 (HU值) +1.
- 在罗莫苏祖马布组中,PJK的发病率显著降低 (18.75%与39.24%,p=.046),特别是PJK-Fx (6.25%与26.58%,p=.019).
- 在罗莫苏祖马布组中,与骨质疏松症相关的并发症较少 (34.38%对比55.70%,p=.011).
结论:
- 术前使用罗莫苏祖马布有效增加骨密度,降低脊髓融合后PJK,PJK-Fx和相关并发症的风险.
- 这些发现表明,罗莫苏祖马布可以提高骨质量,有助于改善外科手术结果和减少不良事件.
- 需要进一步的研究来证实长期疗效和优化治疗方案.
更多相关视频
04:19Minimally Invasive Treatment for Thoracolumbar Burst Fracture Using Sagittal Alignment Screws and A Trauma Reduction Device
Published on: November 8, 2024
355
07:44Evaluation of Patients' Posture and Gait Profile After Lumbar Fusion Surgery by Video Rasterstereography and Treadmill Gait Analysis
Published on: March 23, 2019
17.6K
相关概念视频
Fractures: Bone Repair
2.9K
Treatment for a fracture is based on the type of break, the bone affected, and the patient's age.
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the...
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the...
2.9K
Osteoclasts in Bone Remodeling
2.8K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
2.8K
Bone Remodeling
38.1K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.1K
Bone Formation by Intramembranous Ossification
5.5K
Intramembranous ossification is one of the two processes involved in the development of bones within an embryo. The flat bones of the face, most of the cranial bones, and the clavicles are formed via this process. During intramembranous ossification, the bones develop directly from sheets of undifferentiated mesenchymal connective tissue.
The process begins when mesenchymal cells in the embryonic skeleton gather together and differentiate into osteogenic cells, which then develop into ...
The process begins when mesenchymal cells in the embryonic skeleton gather together and differentiate into osteogenic cells, which then develop into ...
5.5K
Bone Disorders
3.4K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.4K
